B & T Capital Management DBA Alpha Capital Management Makes New Investment in Kenvue Inc. $KVUE

Key Points

• Alpha Capital Management acquired 265,605 Kenvue shares worth approximately $5.1 million in the second quarter. Institutional investors collectively own 97.64% of the company.
• Analysts maintain a cautious outlook, with a consensus “Hold” rating and an average price target of $19.27; recent actions included target-price cuts and downgrades.
• Kenvue’s latest quarterly results narrowly missed estimates, with $0.31 earnings per share and $3.96 billion in revenue, although revenue rose 3% year over year. The company pays a $0.21 quarterly dividend, yielding about 4.5% annually.

B & T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 265,605 shares of the company's stock, valued at approximately $5,076,000.

A number of other large investors also recently modified their holdings of the company. BlackRock Inc. bought a new position in Kenvue in the 2nd quarter worth approximately $2,882,279,000. Norges Bank bought a new stake in shares of Kenvue during the fourth quarter valued at approximately $756,862,000. Independent Franchise Partners LLP raised its position in shares of Kenvue by 56.3% during the fourth quarter. Independent Franchise Partners LLP now owns 48,146,476 shares of the company's stock valued at $830,527,000 after buying an additional 17,343,785 shares during the last quarter. Sculptor Capital LP lifted its holdings in shares of Kenvue by 1,023.5% in the fourth quarter. Sculptor Capital LP now owns 12,886,328 shares of the company's stock worth $222,289,000 after buying an additional 11,739,328 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Kenvue in the second quarter worth $192,080,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Barclays raised their target price on shares of Kenvue from $18.00 to $19.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. Weiss Ratings upgraded shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research note on Monday, June 15th. Zacks Research downgraded shares of Kenvue from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th. UBS Group cut their price objective on Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research report on Tuesday, August 11th. Finally, Wall Street Zen cut Kenvue from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $19.27.

Kenvue Price Performance

Kenvue stock opened at $18.83 on Tuesday. The company has a market cap of $36.17 billion, a price-to-earnings ratio of 21.64, a PEG ratio of 1.37 and a beta of 0.47. The firm's fifty day moving average is $18.98 and its 200 day moving average is $18.15. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $21.84.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The business had revenue of $3.96 billion for the quarter, compared to the consensus estimate of $3.97 billion. During the same quarter last year, the business earned $0.29 EPS. Kenvue's revenue for the quarter was up 3.0% compared to the same quarter last year. Sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 4.5%. The ex-dividend date of this dividend is Wednesday, August 12th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is 96.55%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source